Erin Mistry bought $15k of CRMD
EVP, Chief Commercial Officer at CorMedix Inc.. 1,500 shares at an average of $9.99, traded Oct 31, 2024, filed Dec 13, 2024.
Score components
- +15RoleOfficer
- 0Trade size$15k at market
- 0Relative to holdingsHoldings up 3.0%
- 0Price contextNo price history yet
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +33.5%, 3m +24.9%, 6m +73.7%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000899140-24-001352, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Oct 31, 2024 | POpen-market purchase Common Stock | +1,500 | $9.99 | $15k | 52,011 | Dec 13, 2024 |
Related signals
Other insiders at CorMedix Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 8Weak | CorMedix Inc. | Janet Dillione director | $69k 10,000 shares | -21% | |
| 11Weak | CorMedix Inc. | Alan W Dunton director | $260k 20,000 shares | -33% | |
| 20Weak | CorMedix Inc. | Joseph Todisco Chief Executive Officer | $360k 30,000 shares | -6% | |
| 21Weak | CorMedix Inc. | Janet Dillione director | $408k 34,000 shares | -41% | |
| 58Moderate | CorMedix Inc. | Steven W Lefkowitz director | $475k 40,000 shares | -33% | |
| 15Weak | CorMedix Inc. | Janet Dillione director | $467k 46,657 shares | -49% | |
| 23Weak | CRMDsell CorMedix Inc. | Janet Dillione director | $262k 26,343 shares | -35% | |
| 40Moderate | CRMDsell CorMedix Inc. | Janet Dillione director | $343k 30,000 shares | -38% | |
| 40Moderate | CRMDbuy CorMedix Inc. | Myron Kaplan director | $276k 25,000 shares | +14% | |
| 31Weak | CorMedix Inc. | Alan W Dunton director | $131k 10,000 shares | -20% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.